dolutegravir-containing antiretroviral therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dolutegravir-containing antiretroviral therapy, covering 2021-11-10 to 2021-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants [Phase 3]